阿尔茨海默病中的克洛托蛋白:饮食导致不朽?
Kamil Walczak1, Weronika Kołodziejczyk1, Magdalena Pszczołowska1
1Faculty of Medicine, Wrocław Medical University, Wrocław, Poland.
Journal of Alzheimer's disease : JAD
|July 2, 2025
概括
克洛托蛋白显示神经保护作用有利于阿尔茨海默病 (AD) 和认知功能. 饮食模式,如地中海饮食,可能会影响Klotho水平,为AD提供治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 生物化学 生化学
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,病因不明.
- 目前的阿尔茨海默病治疗方法的疗效有限,这凸显了对新型治疗点的需求.
- 内生因素,如Klotho蛋白,正在成为AD进展的潜在调节者.
研究的目的:
- 审查克洛托蛋白在阿尔茨海默病 (AD) 中的作用.
- 探索Klotho的生物功能,表达模式和AD治疗潜力.
- 在AD的背景下,研究Klotho水平和饮食模式之间的关系.
主要方法:
- 进行了全面的文献审查.
- 分析了关于克洛托蛋白,其神经保护作用以及在阿尔茨海默病中饮食相关性的现有研究.
主要成果:
- 克洛托蛋白对细胞代谢和神经保护至关重要.
- 高Klotho水平与改善的认知功能和减少神经退行相关.
- 特定的饮食模式,如地中海饮食,可能会增强Klotho表达.
结论:
- 克洛托蛋白是减缓AD进展的有希望的治疗点.
- 饮食干预可以影响Klotho水平并影响AD.
- 需要进一步的研究来阐明调节克洛托及其饮食相互作用的机制,以预防和治疗阿尔茨海默病.
关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.克洛托蛋白是一种克洛托蛋白质.地中海饮食 地中海饮食认知能力下降 认知能力下降饮食影响饮食的影响.神经退行症的神经退行症神经保护神经保护维生素 维生素 维生素 是一种更多相关视频
08:52Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
Published on: April 6, 2022
3.6K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
相关概念视频
Aging
193
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
193
The Effect of Aging on Tissues
2.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.6K
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Mitochondria
15.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
15.1K
Alzheimer's Disease: Overview
678
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
678
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
